Stock listing

Xetra:GIS Gilead Sciences, Inc. Aktie

German listing (Xetra) of Gilead Sciences, Inc. · home listing NASDAQ:GILD

Follow Gilead Sciences, Inc. into a list and get an email when it puts out news.

Share price · XETR:GIS

€141.62 EUR +1.60 (+1.1%)

Close on Oct 27, 2026

Day range
€140.46 – €142.00 EUROct 27, 2026
Volume
490 sharesOct 27, 2026
Market cap
€175.6B EURAt the close on Oct 27, 2026 · price × 1.24B shares outstanding
Gilead Sciences, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:GILD · Home$170.68 USD+5.07 (+3.1%)11,363,966$170.00$175.65$169.00$165.61Close on Oct 30, 2026
TSX:GILD$31.95 CAD+0.54 (+1.7%)4,698$31.71$31.97$31.42$31.41Close on Oct 27, 2026
Xetra:GIS€141.62 EUR+1.60 (+1.1%)490€141.72€142.00€140.46€140.02Close on Oct 27, 2026
Cboe Canada:GILD$31.78 CAD+0.37 (+1.2%)1,600$31.65$31.86$31.65$31.41Close on Oct 27, 2026
BMV:GILD$2,934.73 MXN+24.73 (+0.8%)385$2,934.73$2,934.73$2,934.73$2,910.00Close on Oct 27, 2026
Frankfurt:GIS€154.34 EUR+13.02 (+9.2%)1,801€151.40€156.00€151.40€141.32Close on Oct 30, 2026
B3:GILD3470.79 BRL+4.71 (+7.1%)14669.9470.8769.7066.08Close on Oct 27, 2026
Dusseldorf:GIS€154.36 EUR+12.92 (+9.1%)—€151.08€154.36€151.08€141.44Close on Oct 30, 2026
Munich:GIS€141.58 EUR+2.22 (+1.6%)—€141.58€141.58€141.58€139.36Close on Oct 27, 2026
Hamburg:GIS€154.30 EUR+12.90 (+9.1%)—€151.34€154.30€150.78€141.40Close on Oct 30, 2026
Ticker
Xetra:GIS
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Xetra
Currency
EUR

What changed lately

Calls

Replays

  • Gilead Sciences (NASDAQ:GILD) Q3 2026 Earnings Call

    Thu, Oct 29, 2026 · 4:30 PM ET

    Watch Transcript

  • Gilead Sciences (NASDAQ:GILD) Q2 2026 Earnings Call

    Tue, Aug 04, 2026 · 4:30 PM ET

    Watch Transcript

  • Gilead Sciences (NASDAQ:GILD) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor Conferences

Oct 30, 2026

Third Quarter 2026 Summary of Remarks

Oct 29, 2026

Gilead Sciences Announces Third Quarter 2026 Financial Results

Oct 29, 2026

Canadians Living with Primary Biliary Cholangitis (PBC) One Step Closer to New Treatment Option as Gilead Reaches Milestone National Agreement for LYVDELZI® (seladelpar)

Oct 27, 2026

Gilead to Acquire Investigational Oral IL-23R Inhibitor HCXT-2001, Strengthening Its Inflammation Pipeline in IBD

Oct 22, 2026

Gilead to Present New Data on Treatment Response and Long-Term Management of Rare Liver Diseases at The Liver Meeting® 2026

Oct 22, 2026

Gilead to Present New Data Across HIV and Emerging Antiviral Research at IDWeek 2026

Oct 19, 2026

Phase 2 SWIFT Study of Emvistegrast, a Potential Differentiated Once-daily Oral Treatment, Meets Primary Endpoint in Ulcerative Colitis

Oct 19, 2026

Gilead Sciences to Release Third Quarter 2026 Financial Results on Thursday, October 29, 2026

Oct 15, 2026

Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF

Sep 17, 2026

All Gilead Sciences, Inc. news

Decks

Gilead Sciences, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
86 in the last 12 months · 373 in all · newest Oct 30, 2026 · oldest 2020
Calls
26 calls with a replay · 26 with a transcript · latest Oct 29, 2026
Decks
47 decks · latest Oct 29, 2026

Where Gilead Sciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:GILD · Home listingNASDAQUnited StatesUSD
gettex:GISgettexGermanyEUR
Tradegate:GISTradegateGermanyEUR
BCBA:GILDBCBAArgentinaARS
TSX:GILDTSXCanadaCAD
Xetra:GIS · This pageXetraGermanyEUR
Cboe Canada:GILDCboe CanadaCanadaCAD
Milan:1GILDMilanItalyEUR
LS Exchange:885823LS ExchangeGermanyEUR
BMV:GILDBMVMexicoMXN
Lang & Schwarz:885823Lang & SchwarzGermanyEUR
Frankfurt:GISFrankfurtGermanyEUR
BCBA:GILDDBCBAArgentinaUSD
Stuttgart:GISStuttgartGermanyEUR
B3:GILD34B3BrazilBRL
BOATS:GILDBOATSUnited StatesUSD
SIX Swiss:GILDSIX SwissSwitzerlandCHF
LSIN:0QYQLSINUnited KingdomUSD
BIVA:GILDBIVAMexicoMXN
EUROTLX:4GILDEUROTLXItalyEUR
BCBA:GILDCBCBAArgentinaUSD
VIE:GILDViennaAustriaEUR
Dusseldorf:GISDusseldorfGermanyEUR
Munich:GISMunichGermanyEUR
Aquis:GISDAquisUnited KingdomEUR
BCS:GILDBCSChileUSD
Hamburg:GISHamburgGermanyEUR
BCS:GILDCLBCSChileCLP
Aquis:GISDAquisUnited KingdomEUR
BVL:GILDUSBVLPeruPEN
BX Swiss:GISBX SwissSwitzerlandCHF
BCBA:GILDBBCBAArgentinaARS
Frankfurt:GIS0FrankfurtGermanyEUR
Hanover:GISHanoverGermanyEUR
SIX Swiss:GILD.USDSIX SwissSwitzerlandUSD
Turquoise:GILDNTurquoiseUnited KingdomUSD
BCBA:GILD.CIBCBAArgentinaARS

Log in to ask 6ix AI your own questions about Gilead Sciences, Inc.